Andrew Sochacki

743 total citations
16 papers, 537 citations indexed

About

Andrew Sochacki is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Andrew Sochacki has authored 16 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Andrew Sochacki's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Andrew Sochacki is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Andrew Sochacki collaborates with scholars based in United States and Canada. Andrew Sochacki's co-authors include Maria Tikhonenko, Madalina Opreanu, Julia V. Busik, Kelly M. McSorley, Gavin E. Reid, Todd A. Lydic, Maria B. Grant, Sergio Li Calzi, Walter J. Esselman and Dennis L. Guberski and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

In The Last Decade

Andrew Sochacki

16 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Sochacki United States 9 267 156 80 75 73 16 537
Maria Tikhonenko United States 7 287 1.1× 174 1.1× 31 0.4× 75 1.0× 39 0.5× 10 562
Madalina Opreanu United States 8 275 1.0× 177 1.1× 22 0.3× 77 1.0× 34 0.5× 8 572
Guoxu Xu China 16 329 1.2× 441 2.8× 114 1.4× 180 2.4× 27 0.4× 27 794
P. Senanayake United States 14 267 1.0× 209 1.3× 9 0.1× 77 1.0× 32 0.4× 23 772
Jacob Sterling United States 13 142 0.5× 172 1.1× 58 0.7× 26 0.3× 43 0.6× 19 416
Tahira Lemtalsi United States 17 391 1.5× 400 2.6× 12 0.1× 127 1.7× 18 0.2× 33 1.0k
Muriel B. Sättler Germany 16 251 0.9× 173 1.1× 90 1.1× 50 0.7× 23 0.3× 22 784
Tamim Qaum United States 3 344 1.3× 569 3.6× 26 0.3× 282 3.8× 20 0.3× 4 834
Lichun Zhong United States 4 331 1.2× 555 3.6× 45 0.6× 299 4.0× 12 0.2× 7 794
Biju Joseph United States 10 241 0.9× 52 0.3× 39 0.5× 13 0.2× 19 0.3× 18 440

Countries citing papers authored by Andrew Sochacki

Since Specialization
Citations

This map shows the geographic impact of Andrew Sochacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Sochacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Sochacki more than expected).

Fields of papers citing papers by Andrew Sochacki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Sochacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Sochacki. The network helps show where Andrew Sochacki may publish in the future.

Co-authorship network of co-authors of Andrew Sochacki

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Sochacki. A scholar is included among the top collaborators of Andrew Sochacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Sochacki. Andrew Sochacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mack, Taralynn, Caitlyn Vlasschaert, Alexander J. Silver, et al.. (2024). Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics. Journal of Molecular Diagnostics. 26(7). 563–573. 16 indexed citations
2.
Kishtagari, Ashwin, Yajing Li, Caitlyn Vlasschaert, et al.. (2024). Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood Cancer Journal. 14(1). 6–6. 4 indexed citations
4.
Sochacki, Andrew, Jan A. Burger, Wijith Munasinghe, et al.. (2023). A First-in-Human Phase 1 Study of ABBV-525, a Small-Molecule MALT1 Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 142(Supplement 1). 3101–3101. 3 indexed citations
5.
Sochacki, Andrew, Cosmin A. Bejan, Shilin Zhao, et al.. (2022). Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. Blood Advances. 7(5). 756–767. 8 indexed citations
7.
Moyo, Tamara K., Justin M. Watts, Barry Skikne, et al.. (2019). Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition. Blood. 134(Supplement_1). 4236–4236. 10 indexed citations
8.
Sochacki, Andrew, Adrian Bejan, Shilin Zhao, et al.. (2019). Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis. Blood. 134(Supplement_1). 2959–2959. 1 indexed citations
9.
Sochacki, Andrew, Shilin Zhao, Adrian Bejan, et al.. (2019). JAK2V617F Clonal Hematopoiesis Stratifies By Peripheral Blood Counts.. Blood. 134(Supplement_1). 1203–1203. 1 indexed citations
10.
Bejan, Adrian, Andrew Sochacki, Shilin Zhao, Yaomin Xu, & Michael R. Savona. (2018). Abstract 5303: Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor. Cancer Research. 78(13_Supplement). 5303–5303. 2 indexed citations
11.
Savona, Michael R., Andrew Sochacki, & Melissa A. Fischer. (2016). Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes. OncoTargets and Therapy. 2273–2273. 6 indexed citations
12.
Moyo, Tamara K., Andrew Sochacki, Gregory D. Ayers, et al.. (2016). Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis. Blood. 128(22). 1125–1125. 9 indexed citations
13.
Tikhonenko, Maria, Todd A. Lydic, Madalina Opreanu, et al.. (2013). N-3 Polyunsaturated Fatty Acids Prevent Diabetic Retinopathy by Inhibition of Retinal Vascular Damage and Enhanced Endothelial Progenitor Cell Reparative Function. PLoS ONE. 8(1). e55177–e55177. 77 indexed citations
14.
Opreanu, Madalina, Maria Tikhonenko, Todd A. Lydic, et al.. (2011). The Unconventional Role of Acid Sphingomyelinase in Regulation of Retinal Microangiopathy in Diabetic Human and Animal Models. Diabetes. 60(9). 2370–2378. 80 indexed citations
15.
Tikhonenko, Maria, Todd A. Lydic, Yun Wang, et al.. (2009). Remodeling of Retinal Fatty Acids in an Animal Model of Diabetes. Diabetes. 59(1). 219–227. 111 indexed citations
16.
Busik, Julia V., Maria Tikhonenko, Ashay D. Bhatwadekar, et al.. (2009). Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. The Journal of Experimental Medicine. 206(13). 2897–2906. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026